medicines - International Biopharmaceutical Industry

Current Edition

news

Seagen to expand, add jobs with new cancer drug factory

Dive Brief: Seagen, the largest biotechnology company in the Seattle area, has unveiled plans for a manufacturing facility to help provide "greater control and fle...

25 April 2022 news cancer | Drug

Continue Reading →

news

EQRx builds case for cancer drug it hopes can disrupt market

Dive Brief: EQRx, which aims to bring new medicines to market at "radically lower" prices, said the experimental lung cancer drug it co-owns with Chinese biotech C...

20 January 2022 news cancer | Drug

Continue Reading →

news

Novartis to consider sale or separation of Sandoz business

Under CEO Vas Narasimhan, Novartis has slimmed down what was a sprawling conglomerate spanning prescription and generic drugs, eye care and consumer healthcare. The d...

29 October 2021 news Business | Drugs

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Seagen to expand, add jobs with new cancer drug factory

EQRx builds case for cancer drug it hopes can disrupt market

Novartis to consider sale or separation of Sandoz business

International Biopharmaceutical Industry